These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11701737)

  • 1. Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor.
    Ando S; Sarlis NJ; Oldfield EH; Yen PM
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5572-6. PubMed ID: 11701737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance.
    Ando S; Sarlis NJ; Krishnan J; Feng X; Refetoff S; Zhang MQ; Oldfield EH; Yen PM
    Mol Endocrinol; 2001 Sep; 15(9):1529-38. PubMed ID: 11518802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of thyroid hormone receptor beta isoform may cause inappropriate secretion of TSH in a TSH-secreting pituitary adenoma.
    Tagami T; Usui T; Shimatsu A; Beniko M; Yamamoto H; Moriyama K; Naruse M
    J Clin Endocrinol Metab; 2011 Jun; 96(6):E948-52. PubMed ID: 21430027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene.
    Pohlenz J; Weiss RE; Macchia PE; Pannain S; Lau IT; Ho H; Refetoff S
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3919-28. PubMed ID: 10566629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Patient With a Thyrotropin-Secreting Microadenoma and Resistance to Thyroid Hormone (P453T).
    Teng X; Jin T; Brent GA; Wu A; Teng W; Shan Z
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2511-4. PubMed ID: 25867808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity.
    Yagi H; Pohlenz J; Hayashi Y; Sakurai A; Refetoff S
    J Clin Endocrinol Metab; 1997 May; 82(5):1608-14. PubMed ID: 9141558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
    Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
    Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An abnormality of thyroid hormone receptor expression may explain abnormal thyrotropin production in thyrotropin-secreting pituitary tumors.
    Gittoes NJ; McCabe CJ; Verhaeg J; Sheppard MC; Franklyn JA
    Thyroid; 1998 Jan; 8(1):9-14. PubMed ID: 9492147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel resistance to thyroid hormone associated with a new mutation (T329N) in the thyroid hormone receptor beta gene.
    Sarkissian G; Dace A; Mesmacque A; Bony-Trifunovic H; Malezet-Desmoulins C; Torresani J; Margotat A
    Thyroid; 1999 Feb; 9(2):165-71. PubMed ID: 10090317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A de novo mutation in an already mutant nucleotide of the thyroid hormone receptor beta gene perpetuates resistance to thyroid hormone.
    Lado-Abeal J; Dumitrescu AM; Liao XH; Cohen RN; Pohlenz J; Weiss RE; Lebrethon MC; Verloes A; Refetoff S
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1760-7. PubMed ID: 15598685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele.
    Suzuki H; Zhang XY; Forrest D; Willingham MC; Cheng SY
    Mol Endocrinol; 2003 May; 17(5):895-907. PubMed ID: 12576488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to thyroid hormone caused by a new mutation (V336M) in the thyroid hormone receptor beta gene.
    Pohlenz J; Schönberger W; Koffler T; Refetoff S
    Thyroid; 1999 Oct; 9(10):1001-4. PubMed ID: 10560954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic characteristics of a large monocentric series of patients affected by thyroid hormone (Th) resistance and suggestions for differential diagnosis in patients without mutation of Th receptor β.
    Macchia E; Lombardi M; Raffaelli V; Piaggi P; Macchia L; Scattina I; Martino E
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):921-8. PubMed ID: 25040256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to thyroid hormone in a patient without thyroid hormone receptor mutations.
    Parikh S; Ando S; Schneider A; Skarulis MC; Sarlis NJ; Yen PM
    Thyroid; 2002 Jan; 12(1):81-6. PubMed ID: 11838736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation (M310L) in the thyroid hormone receptor beta causing resistance to thyroid hormone in a Brazilian kindred and a neonate.
    Furlanetto TW; Kopp P; Peccin S; Gu WX; Jameson JL
    Mol Genet Metab; 2000 Nov; 71(3):520-6. PubMed ID: 11073720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation (E333D) in the thyroid hormone beta receptor causing resistance to thyroid hormone syndrome.
    Maraninchi M; Bourcigaux N; Dace A; El-Yazidi C; Malezet-Desmoulins C; Krempf M; Torresani J; Margotat A
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):569-76. PubMed ID: 17177139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel point mutation in cluster 3 of the thyroid hormone receptor beta gene (P247L) causing mild resistance to thyroid hormone.
    Pohlenz J; Manders L; Sadow PM; Kansal PC; Refetoff S; Weiss RE
    Thyroid; 1999 Dec; 9(12):1195-203. PubMed ID: 10646658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both thyroid hormone receptor (TR)beta 1 and TR beta 2 isoforms contribute to the regulation of hypothalamic thyrotropin-releasing hormone.
    Dupré SM; Guissouma H; Flamant F; Seugnet I; Scanlan TS; Baxter JD; Samarut J; Demeneix BA; Becker N
    Endocrinology; 2004 May; 145(5):2337-45. PubMed ID: 14726446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant inhibition of thyroid hormone action selectively in the pituitary of thyroid hormone receptor-beta null mice abolishes the regulation of thyrotropin by thyroid hormone.
    Abel ED; Moura EG; Ahima RS; Campos-Barros A; Pazos-Moura CC; Boers ME; Kaulbach HC; Forrest D; Wondisford FE
    Mol Endocrinol; 2003 Sep; 17(9):1767-76. PubMed ID: 12819298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary resistance to thyroid hormone syndrome is associated with T3 receptor mutants that selectively impair beta2 isoform function.
    Wan W; Farboud B; Privalsky ML
    Mol Endocrinol; 2005 Jun; 19(6):1529-42. PubMed ID: 15802373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.